Lymphoma Diagnosis and Treatment
Most cited papers
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood · 2016 · 8,061 citations
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine · 2017 · 6,172 citations
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology · 2014 · 5,873 citations
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine · 2002 · 5,644 citations
- Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaProceedings of the National Academy of Sciences · 2002 · 5,117 citations
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine · 1993 · 5,039 citations
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology · 2007 · 4,452 citations
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsLeukemia · 2022 · 4,448 citations
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood · 2003 · 4,334 citations
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell LymphomaNew England Journal of Medicine · 2018 · 4,230 citations
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's LymphomaNew England Journal of Medicine · 2014 · 3,599 citations
Metadata from OpenAlex (CC0).